{"id":"https://openalex.org/W2147133240","doi":"https://doi.org/10.1177/14746514060060010201","title":"Review: Fibrates: therapeutic review","display_name":"Review: Fibrates: therapeutic review","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2147133240","doi":"https://doi.org/10.1177/14746514060060010201","mag":"2147133240"},"language":"en","primary_location":{"id":"doi:10.1177/14746514060060010201","doi":"https://doi.org/10.1177/14746514060060010201","is_oa":false,"landing_page_url":"https://doi.org/10.1177/14746514060060010201","pdf_url":null,"source":{"id":"https://openalex.org/S163587207","display_name":"The British Journal of Diabetes","issn_l":"1474-6514","issn":["1474-6514","1753-4305"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British Journal of Diabetes &amp; Vascular Disease","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2147133240"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061389868","display_name":"M. John Chapman","orcid":"https://orcid.org/0000-0003-3712-5184","observed_orcids":["https://orcid.org/0000-0003-3712-5184"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M John Chapman","raw_affiliation_strings":["Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Unit\u00e9 551, Dyslipoprot\u00e9inemies et Ath\u00e9roscl\u00e9rose: G\u00e9n\u00e9tique, M\u00e9tabolisme et Th\u00e9rapeutique, H\u00f4pital de la Piti\u00e9, 83, Bd de l'H\u00f4pital \u2014 Pavilion B. Delessert, 75651 Paris, Cedex 13, France,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), Unit\u00e9 551, Dyslipoprot\u00e9inemies et Ath\u00e9roscl\u00e9rose: G\u00e9n\u00e9tique, M\u00e9tabolisme et Th\u00e9rapeutique, H\u00f4pital de la Piti\u00e9, 83, Bd de l'H\u00f4pital \u2014 Pavilion B. Delessert, 75651 Paris, Cedex 13, France,","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5061389868"],"corresponding_institution_ids":["https://openalex.org/I154526488"],"apc_list":null,"apc_paid":null,"fwci":1.4905,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.83315293,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"6","issue":"1","first_page":"11","last_page":"19"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.01360000018030405,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fibrates","display_name":"fibrates","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pparalpha-agonists","display_name":"PPAR\u03b1 agonist","score":0.9200000166893005},{"id":"https://openalex.org/keywords/atherogenic-dyslipidemia","display_name":"atherogenic dyslipidemia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/triglyceride-lowering","display_name":"triglyceride lowering","score":0.7310000061988831},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9769999980926514},{"id":"https://openalex.org/keywords/ldl-particle-size","display_name":"LDL particle size","score":0.8410000205039978},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9380000233650208},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.996999979019165},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.8180000185966492},{"id":"https://openalex.org/keywords/field-trials","display_name":"field trials","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cardiovascular-risk-reduction","display_name":"cardiovascular risk reduction","score":0.699999988079071},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/microvascular-disease","display_name":"microangiopathy","score":0.6190000176429749}],"concepts":[{"id":"https://openalex.org/C2776933373","wikidata":"https://www.wikidata.org/wiki/Q424744","display_name":"Fibrate","level":3,"score":0.9807955026626587},{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9686379432678223},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7928541898727417},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6021680235862732},{"id":"https://openalex.org/C2776362216","wikidata":"https://www.wikidata.org/wiki/Q577387","display_name":"Bezafibrate","level":2,"score":0.5348644852638245},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5296157598495483},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.46343547105789185},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.44423675537109375},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.4349515736103058},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.42346060276031494},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4108186364173889},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.4009227752685547},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.39916670322418213},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.35148388147354126}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1177/14746514060060010201","doi":"https://doi.org/10.1177/14746514060060010201","is_oa":false,"landing_page_url":"https://doi.org/10.1177/14746514060060010201","pdf_url":null,"source":{"id":"https://openalex.org/S163587207","display_name":"The British Journal of Diabetes","issn_l":"1474-6514","issn":["1474-6514","1753-4305"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British Journal of Diabetes &amp; Vascular Disease","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W188445981","https://openalex.org/W1521959273","https://openalex.org/W1566044237","https://openalex.org/W1567127662","https://openalex.org/W1671834350","https://openalex.org/W1971175832","https://openalex.org/W1972509999","https://openalex.org/W1988048988","https://openalex.org/W1990166147","https://openalex.org/W2000197810","https://openalex.org/W2005761359","https://openalex.org/W2039146810","https://openalex.org/W2039592725","https://openalex.org/W2050904588","https://openalex.org/W2051826780","https://openalex.org/W2070999659","https://openalex.org/W2073346843","https://openalex.org/W2082375016","https://openalex.org/W2089016920","https://openalex.org/W2090822854","https://openalex.org/W2091630536","https://openalex.org/W2093380242","https://openalex.org/W2095451652","https://openalex.org/W2102707478","https://openalex.org/W2102906564","https://openalex.org/W2106340207","https://openalex.org/W2108886453","https://openalex.org/W2109438674","https://openalex.org/W2118124172","https://openalex.org/W2125692663","https://openalex.org/W2132181466","https://openalex.org/W2132317196","https://openalex.org/W2134854746","https://openalex.org/W2137046761","https://openalex.org/W2143893927","https://openalex.org/W2145666707","https://openalex.org/W2147176408","https://openalex.org/W2148403865","https://openalex.org/W2163521556","https://openalex.org/W2198678228","https://openalex.org/W2321298447","https://openalex.org/W2328529137","https://openalex.org/W2341665659","https://openalex.org/W2400712338","https://openalex.org/W2460467964","https://openalex.org/W2463340387","https://openalex.org/W2464411196","https://openalex.org/W2615845755","https://openalex.org/W4232915119","https://openalex.org/W4238251256","https://openalex.org/W4242186244","https://openalex.org/W4244278365","https://openalex.org/W4249825849"],"related_works":["https://openalex.org/W2062635407","https://openalex.org/W1954904400","https://openalex.org/W2143893927","https://openalex.org/W2121145204","https://openalex.org/W2005965794","https://openalex.org/W2034143111","https://openalex.org/W2403288828","https://openalex.org/W7047899340","https://openalex.org/W2124439283","https://openalex.org/W2151080819"],"abstract_inverted_index":{"As":[0],"agonists":[1],"of":[2,19,24,106,151,196,207,211],"the":[3,17,78,104,126,147,168,191,200,204],"peroxisome":[4],"proliferator-activated":[5],"receptor":[6,81],"\u03b1":[7],"(PPAR\u03b1),":[8],"fibrates":[9,25,84],"are":[10,65,225],"established,":[11],"effective":[12],"and":[13,37,70,97,111,156],"well-tolerated":[14],"agents":[15],"in":[16,29,40,91,109,118,132,136,146,199],"management":[18],"atherogenic":[20],"dyslipidaemia.":[21],"Key":[22],"actions":[23],"include":[26],"a":[27,38,51,137,142,216],"reduction":[28,145,183],"elevated":[30],"triglyceride":[31],"levels":[32],"(by":[33],"up":[34],"to":[35,59,68,130,167,227],"50%)":[36],"rise":[39],"high-density":[41],"lipoprotein":[42,57],"cholesterol":[43],"(HDL-C)":[44],"concentrations":[45],"(typically":[46],"by":[47,77,175,190],"5\u201415%).":[48],"Fibrates":[49],"promote":[50],"shift":[52],"from":[53],"small,":[54],"dense":[55],"low-density":[56],"(LDL)":[58],"larger":[60],"more":[61],"buoyant":[62],"particles,":[63],"which":[64],"less":[66],"susceptible":[67],"oxidation":[69],"possess":[71],"higher":[72],"binding":[73],"affinity":[74],"for":[75,219],"removal":[76],"non-atherogenic":[79],"LDL":[80],"pathway.":[82],"Thus,":[83],"can":[85],"correct":[86],"lipid":[87],"abnormalities":[88],"commonly":[89],"observed":[90],"patients":[92,119],"with":[93,120,160,184],"type":[94,121],"2":[95,122],"diabetes":[96],"metabolic":[98],"syndrome.":[99],"Clinical":[100],"evidence":[101],"has":[102],"demonstrated":[103],"value":[105],"fibrate":[107,128,220],"therapy":[108,198],"secondary":[110,169],"primary":[112,138,148],"prevention":[113,139],"settings,":[114],"as":[115,117],"well":[116],"diabetes.":[123],"However,":[124,203],"FIELD,":[125],"largest":[127],"study":[129],"date":[131],"diabetic":[133],"patients,":[134],"predominantly":[135],"setting,":[140],"showed":[141],"non-significant":[143],"11%":[144,176],"end":[149,170],"point":[150],"coronary":[152],"heart":[153],"disease":[154],"death":[155],"non-fatal":[157],"myocardial":[158],"infarction":[159],"fenofibrate,":[161],"although":[162,222],"total":[163],"cardiovascular":[164],"events,":[165],"corresponding":[166],"point,":[171],"were":[172],"significantly":[173],"reduced":[174],"(p=0.035).":[177],"It":[178],"is":[179],"possible":[180],"that":[181],"risk":[182],"fenofibrate":[185,208],"may":[186],"have":[187],"been":[188],"attenuated":[189],"two-fold":[192],"greater":[193],"drop-in":[194],"use":[195],"statin":[197],"placebo":[201],"group.":[202],"interesting":[205],"results":[206],"on":[209],"attenuation":[210],"microangiographic":[212],"symptomatology":[213],"potentially":[214],"suggest":[215],"new":[217],"recommendation":[218],"therapy,":[221],"further":[223],"studies":[224],"required":[226],"validate":[228],"these":[229],"findings.":[230]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2147133240","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
